Bausch Health Companies Inc.
BHC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000885590
In the last 90 days, Bausch Health Companies Inc. insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $1.18B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Bausch Health Companies Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 224
- +15 vs. Q3 2024
- Shares held
- 253.2M
- −1.77M (−0.7%) vs. Q3 2024
- Total value
- $1.99B
- −$92.5M (−4.4%) vs. Q3 2024
- New holders
- 39
- 53 more added
- Sold out
- 24
- 76 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $1.18B |
| Q1 2026 | 227 | $1.27B |
| Q4 2025 | 236 | $1.64B |
| Q3 2025 | 218 | $1.55B |
| Q2 2025 | 211 | $1.64B |
| Q1 2025 | 229 | $1.58B |
| Q4 2024 | 224 | $1.99B |
| Q3 2024 | 211 | $2.08B |
| Q2 2024 | 234 | $1.96B |
| Q1 2024 | 236 | $2.95B |
| Q4 2023 | 233 | $2.29B |
| Q3 2023 | 223 | $2.33B |
| Q2 2023 | 231 | $2.12B |
| Q1 2023 | 234 | $2.25B |
| Q4 2022 | 261 | $1.81B |
| Q3 2022 | 282 | $1.70B |
| Q2 2022 | 327 | $2.02B |
| Q1 2022 | 368 | $5.87B |
| Q4 2021 | 376 | $7.25B |
| Q3 2021 | 346 | $7.16B |
| Q2 2021 | 357 | $7.48B |
| Q1 2021 | 352 | $7.87B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Bausch Health Companies Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hillsdale Investment Management Inc. | 1,548,468 | $12.5M | 0.63% | +1,548,468 | New |
| Hein Park Capital Management LP | 1,853,379 | $14.9M | 11.48% | −2000.0% | Reduced |
| Compass Rose Asset Management, LP | 2,100,000 | $16.9M | 8.29% | +1,650,000+366.7% | Added |
| Deutsche Bank AG | 2,129,711 | $17.2M | 0.01% | −440,630−17.1% | Reduced |
| Laurion Capital Management LP | 2,743,465 | $22.1M | 1.38% | −340,591−11.0% | Reduced |
| BNP Paribas Arbitrage, SA | 2,996,125 | $24.1M | 0.02% | −11,049−0.4% | Reduced |
| Dimensional Fund Advisors LP | 3,113,107 | $25.1M | 0.01% | +90,166+3.0% | Added |
| SG Americas Securities, LLC | 3,301,981 | $26.6M | 0.12% | +1,263,706+62.0% | Added |
| Arrowstreet Capital, Limited Partnership | 4,770,793 | $38.5M | 0.03% | +1,510,445+46.3% | Added |
| Citadel Advisors LLC | 5,200,796 | $41.9M | 0.04% | +55,804+1.1% | Added |
| Kohlberg Kravis Roberts & Co. L.P. | 5,235,000 | $42.2M | 1.13% | 00.0% | Unchanged |
| Maple Rock Capital Partners Inc. | 5,300,000 | $42.7M | 3.11% | +3,235,100+156.7% | Added |
| Franklin Resources Inc | 5,316,822 | $42.9M | 0.01% | +56,446+1.1% | Added |
| MFN Partners Management, LP | 6,000,000 | $48.4M | 0.95% | 00.0% | Unchanged |
| Mizuho Markets Americas LLC | 7,000,000 | $56.4M | 1.08% | 00.0% | Unchanged |
| ING Groep NV | 7,500,000 | $60.5M | 0.41% | 00.0% | Unchanged |
| Royal Bank of Canada | 11,188,348 | $90.2M | 0.02% | −6,003−0.1% | Reduced |
| Nomura Holdings Inc | 11,345,000 | $91.4M | 0.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 11,684,859 | $94.5M | 0.00% | +145,078+1.3% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 13,000,000 | $104.8M | 0.22% | 00.0% | Unchanged |
| National Bank of Canada | 15,416,939 | $124.3M | 0.16% | −227,279−1.5% | Reduced |
| Paulson & Co. Inc. | 26,439,035 | $213.1M | 12.90% | 00.0% | Unchanged |
| Goldentree Asset Management LP | 27,540,075 | $221.7M | 17.03% | −1,855,670−6.3% | Reduced |
| Icahn Carl CSuperinvestorIcahn Capital | 34,721,118 | $279.9M | 3.77% | 00.0% | Unchanged |
| Proequities, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −1,530,914−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −1,424,000−100.0% | Sold out |
| Lombard Odier Asset Management (USA) Corp | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −273,837−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −271,211−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −114,898−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −60,972−100.0% | Sold out |
| Pinnacle Associates Ltd | 0 | $0 | 0.00% | −29,500−100.0% | Sold out |
| IMC-Chicago, LLC | 0 | $0 | 0.00% | −27,668−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −21,600−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,238−100.0% | Sold out |
| Camden Capital, LLC | 0 | $0 | 0.00% | −10,840−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −3,700−100.0% | Sold out |
| Stone House Investment Management, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Plato Investment Management Ltd | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| McMahon Financial Advisors, LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −23,460−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| FinTrust Capital Advisors, LLC | – | – | – | – | Not filed |